prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Normal, RUN DATE: RUN TIME: RUN USER. ACCT # : LOC: AGE/SX: /F. ROOM. REG DR: BED: SPEC # : RECD: COLL: TIME IN FORMALIN: hrs. COLD ISCHEMA TIME. mins. CLINICAL INFORMATION : Pre-Op Diagnosis: Remarks: Specimen (s) : A. Left breast skin biopsy. B. Left breast lumpectomy - stitch marks area of interest. C. Left breast frozen section. MICROSCOPIC DIAGMOSIS. A. "LEFT BREAST SKIN BIOPSY": INVASIVE CARCINOMA WITH EXTENSIVE VASCULAR LYMPHATIC INVASION. B. "LEFT BREAST LUMPECTOMY STITCH MARKS AREA OF INTEREST": INVASIVE DUCTAL CARCINOMA. RECEPTORS, HER2/NEU, KI-67 ANALYSIS PENDING. SEE COMMENT FOR DETAILS. C. "LEFT BREAST": INVASIVE DUCTAL CARCINOMA. COMMENT(S). COLLEGE OF AMERICAN PATHOLOGISTS PROTOCOL FOR THE EXAMINATION OF SPECIMENS WITH. INVASIVE CARCINOMA OF THE BREAST. BASED ON AJCC/UICC TNM, 7TH EDITION. The following classification should be adjusted based on additional clinical information. PROCEDURE: Excision without wire-guided localization,. skin biopsy. left breast biopsy. LYMPH NODE SAMPLING: No lymph nodes identified. SPECIMEN LATERALITY: Left. HISTOLOGIC TYPE OF INVASIVE CARCINOMA: Invasive ductal carcinoma. TUMOR SIZE: 2.0 cm. HISTOLOGIC GRADE: Grade 3. Tubular Differentiation Score 3. Nuclear Pleomorphism Score: 3. Mitotic Rate Score 2. TUMOR FOCALITY: Single focus of invasive carcinoma. DUCTAL CARCINOMA IN SITU: Present high grade, not extensive. RUN DATE. RUN TIME. RUN USER: SPEC #: COMMENT (S). MACROSCOPIC/MICROSCOPIC EXTENT OF TUMOR: Skin: Invasive carcinoma directly invades into. dermis without ulceration. MARGINS. Margins involved by invasive carcinoma. Margins uninvolved by ductal carcinoma in situ. LYMPH NODES: No lymph nodes identified. LYMPH-VASCULAR INVASION: Present. DERMAL-LYMPHATIC INVASION. Present. PATHOLOGIC STAGING: Primary Tumor : pT1c. Lymph Nodes pNX. Distant Metastasis: Not applicable. ANCILLARY STUDIES: Receptors. Her2/Neu, Ki-67 analysis pending. ADDITIONAL PATHOLOGIC FINDINGS: Fibrocystic changes. GROSS DESCRIPTION: A. In formalin labeled with the patient's name and "left breast skin biopsy" is a 3 x 0.8. x 1. 5 cm wedge biopsy of brown skin and underlying fatty tissue. The specimen is bisected. lengthwise and totally submitted in blocks A1 and A2. B. Received fresh labeled with the patient's name and "left breast lumpectomy. stitch. marks area of interest" is a 7 gram aggregate of fibroadipose tissue. The specimen. measures 6 x 5 x 2 cm. There is one portion which is sutured. and this portion measures. 4 x 2 x 1.5 cm. On cross section. this portion shows an admixture of adipose tissue and. streaky gray-white tissue possibly representing tumor. A section of this portion is. submitted in blocks B1-B3. Additional sections of the other fragments of tissue are. submitted in blocks B4-B6. C. Received fresh for frozen section labeled with the patient's name and "left breast" are. several fragments of firm. fatty tissue which measure together 2.5 x 2 x 1 cm. A. representative portion of the firmer area is submitted in block C1 for frozen section. À. cytologic scrape prep is prepared for Diff-Quik stain. The complimentary tissue submitted. for frozen section is provided to the Tissue Bank coordinator The remainder of the soft. tissue is submitted in block C2 for permanent section. MICROSCOPIC DESCRIPTION: E-cadherin stains on specimens B and C demonstrate that they are positive. Control. block. stained appropriately. INTRAOPERATIVE CONSULTATION: C. FROZEN SECTION DIAGNOSIS, LEFT BREAST BIOPSY: MALIGNANT CONSISTENT WITH INVASIVE CARCINOMA, POSSIBLE PLEOMORPHIC LOBULAR. CARCINOMA. TISSUE PROVIDED TO TISSUE BANK COORDINATOR. RESULTS PHONED TO. RUN DATE. RUN TIME. RUN USER. SPEC #: PHOTO DOCUMENITATTON. Image. (signature on file).

expanded version (tokens=1466) : 
 Based on the provided breast pathology report, the following information can be extracted:

1. Histological classification: Invasive ductal carcinoma (IDC) and high-grade ductal carcinoma in situ (DCIS) were identified in the left breast lumpectomy sample and invasive carcinoma with extensive vascular lymphatic invasion was identified in the skin biopsy sample.
2. Subtype: No subtype information is provided.
3. Necrosis: No mention of necrosis in the report.
4. Tumor infiltrating lymphocytes: Some mention of lymphovascular invasion but no specific information on tumor-infiltrating lymphocytes.
5. Histological grade: IDC is grade 3, with Tubular Differentiation Score 3, Nuclear Pleomorphism Score 3, and Mitotic Rate Score 2.
6. Nuclear grade: Grade 3 for IDC.
7. Lymphovascular invasion: Present in both the lumpectomy and skin biopsy samples.
8. Calcification: No mention of calcification in the report.
9. Receptor status: No information provided - "Receptors. Her2/Neu, Ki-67 analysis [are] pending."
10. IHC and ancillary testing results: No specific IHC or ancillary testing results are mentioned in the report, apart from E-cadherin staining being positive on specimens B and C.

Some additional points to note from the report:
- The excision procedure was done without wire-guided localization, skin biopsy, and

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1612) : 
 The breast pathology report shows invasive ductal carcinoma (IDC) and high-grade ductal carcinoma in situ (DCIS) in the left breast lumpectomy sample, and invasive carcinoma with extensive vascular lymphatic invasion in the skin biopsy sample. IDC is grade 3 and lymphovascular invasion is present. Tumor receptor status (Her2/Neu, Ki-67) is pending. No calcification or information on tumor-infiltrating lymphocytes were mentioned in the report.

